Immusoft

Developer of novel therapies designed for the treatment of rare diseases. The company develops autologous cell therapies based on its immune system programming technology that entails collecting a typ...

Healthcare

Seattle, WA, United States

Founded 2009

22 employees

Website

Valuation

$65.2M

Market implied

Share Price

N/A

Total Raised

$54.8M

Last Round

N/A

Investors

+28 other investors

View all 28 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Immusoft's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required